Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS

34.84 Down 0.11(0.31%) 4:00PM EDT|After Hours : 34.84 0.00 (0.00%) 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 305,814   292,237   191,005  
Cost of Revenue57,641  66,567  36,178  
Gross Profit 248,173   225,670   154,827  
Operating Expenses
Research Development53,881  42,108  30,600  
Selling General and Administrative168,690  148,508  132,657  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 25,602   35,054   (8,430)
Income from Continuing Operations
Total Other Income/Expenses Net546  534  583  
Earnings Before Interest And Taxes26,148  35,588  (7,847)
Interest Expense1,880  3,570  3,922  
Income Before Tax24,268  32,018  (11,769)
Income Tax Expense(130,690)1,413   -  
Minority Interest -   -   -  
Net Income From Continuing Ops154,958  30,605  (11,769)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 154,958   30,605   (11,769)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 154,958   30,605   (11,769)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.